PD-1 antibody (intrathecal)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-1 antibody (intrathecal), covering 2025-04-03 to 2025-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26) [Phase 1]